1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Lumbar Hernia/Bleichner's Hernia Global Clinical Trials Review, H2, 2015

Lumbar Hernia/Bleichner's Hernia Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Lumbar Hernia/Bleichner's Hernia Global Clinical Trials Review, H2, 2015" provides an overview of Lumbar Hernia/Bleichner’s Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Lumbar Hernia/Bleichner’s Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Lumbar Hernia/Bleichner's Hernia Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Lumbar Hernia/Bleichner's Hernia to Genito Urinary System And Sex Hormones Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Lumbar Hernia/Bleichner's Hernia to Genito Urinary System And Sex Hormones Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 40
Abbreviations 40
Definitions 40
Research Methodology 41
Secondary Research 41
About GlobalData 42
Contact Us 42
Disclaimer 42
Source 43

List of Tables
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials by Region, 2015* 6
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Lumbar Hernia/Bleichner's Hernia to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 13
Lumbar Hernia/Bleichner's Hernia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Lumbar Hernia/Bleichner's Hernia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Lumbar Hernia/Bleichner's Hernia to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 16
Lumbar Hernia/Bleichner's Hernia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Lumbar Hernia/Bleichner's Hernia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Lumbar Hernia/Bleichner's Hernia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

List of Figures
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Proportion of Lumbar Hernia/Bleichner's Hernia to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 13
Lumbar Hernia/Bleichner's Hernia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Lumbar Hernia/Bleichner's Hernia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Lumbar Hernia/Bleichner's Hernia to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 16
Lumbar Hernia/Bleichner's Hernia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Lumbar Hernia/Bleichner's Hernia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Lumbar Hernia/Bleichner's Hernia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Lumbar Hernia/Bleichner's Hernia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Lumbar Hernia/Bleichner's Hernia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 41

Companies Mentioned
Seikagaku Corporation
Teijin Limited
Physicians' Services Incorporated Foundation
M3, Inc.
ICON Plc

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.